Evidence map›Paper›PMID 40067459›Full record

SynthesisEuropean journal of nuclear medicine and molecular imaging2025

Head-to-Head comparison of [

Priscilla Guglielmo, Rosario Mazzola, Shadya Sara Darwish, Francesco Valenti, Tommaso Martino De Pas, Lucia Setti, Manuela Bonacina, Massimo Maria Grassi, Laura Evangelista

Abstract readComparative StudySystematic Review
PubMed Publisher
In one paragraph

Synthesis in European journal of nuclear medicine and molecular imaging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Real-world application ofEuropean journal of nuclear medicine and molecular imaging · 2026
    Article
  2. CouldDiagnostics (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Priscilla GuglielmoNuclear Medicine Unit, Humanitas Gavazzeni, Bergamo, Italy.ORCID 0000-0001-9150-4367
Rosario MazzolaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy. rosariomazzola@hotmail.it.ORCID 0000-0002-2838-7337
Shadya Sara DarwishBreast Unit, Humanitas Gavazzeni, Bergamo, Italy.ORCID 0000-0002-8742-0942
Francesco ValentiBreast Unit, Humanitas Gavazzeni, Bergamo, Italy.
Tommaso Martino De PasMedical Oncology Unit, Humanitas Gavazzeni, Bergamo, Italy.ORCID 0000-0001-5684-5254
Lucia SettiNuclear Medicine Unit, Humanitas Gavazzeni, Bergamo, Italy.ORCID 0000-0002-7035-0511
Manuela BonacinaNuclear Medicine Unit, Humanitas Gavazzeni, Bergamo, Italy.ORCID 0000-0003-2940-2460
Massimo Maria GrassiBreast Unit, Humanitas Gavazzeni, Bergamo, Italy.ORCID 0000-0001-5903-1205
Laura EvangelistaDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.ORCID 0000-0002-5955-9488

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis review systematically compared, in a head-to-head manner, the diagnostic and prognostic performance of [

methodsA systematic literature search was conducted in PubMed, Scopus, and Web of Science databases up to January 2025, without temporal limitations or restrictions on the number of patients in the included studies, to identify relevant articles comparing the diagnostic value of [

resultsA total of 20 papers were evaluated. Based on the CASP analysis, the quality of the study was variable. Totally, 806 patients affected by BC underwent both [

conclusionThese findings underscore the potential of [

Indexed as

Breast NeoplasmsFluorodeoxyglucose F18Positron Emission Tomography Computed TomographyFemaleHumansPrognosisRadiopharmaceuticalsFluorodeoxyglucose F18RadiopharmaceuticalsBreast cancerFDGFESPET/CTPrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.